With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias||University of California at Santa Cruz / Camilla Forsberg, PhD||Innovation Grants||2013||California|
|An Intersection of Cell Metabolism and Differentiation in Childhood Sarcomas||Cedars-Sinai Medical Center / Sandra Orsulic, PhD||Innovation Grants||2013||California|
|Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL||University of Colorado Denver / Doug Graham, MD, PhD||Reach Grants||2013||Colorado|
|Children's Hospital Colorado Experimental Therapeutics Program||Children's Hospital Colorado / Lia Gore, MD||Phase I/II Infrastructure Grants||2013||Colorado|
|LRP1 and Angiogenesis in Pediatric Malignant Glioma||Mayo Clinic Jacksonville / Takahisa Kanekiyo, MD, PhD||Young Investigator Grants||2013||Florida|
|IDO-based Immunotherapy for Pediatric Brain Tumors||Georgia Health Sciences University Research Institute, Inc. / Theodore Johnson, MD, PhD||'A' Award Grants||2013||Georgia|
|Theranostics in Children and Young Adults||University of Iowa / Sue O'Dorisio, MD, PhD||Springboard Grants||2013||Iowa|
|An Oncolytic Herpes Simplex Virus Restricted in Entry to Neuroblastoma Cells||Northwestern University Medical School / Richard Longnecker, PhD||Innovation Grants||2013||Illinois|
|The Role of Prmt1 in Osteosarcoma Initiation and Metastasis||Dana-Farber Cancer Institute / Hao-Ru Hsu, PhD||Young Investigator Grants||2013||Massachusetts|
|Histone Modification and Hmgn1 Overexpression as Drivers of B-ALL with Polysomy 21||Dana-Farber Cancer Institute / Andrew Lane, MD, PhD||Young Investigator Grants||2013||Massachusetts|